Visiomed Group SA

Equities

ALVMG

FR0013481835

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 16:35:02 24/05/2024 BST			5-day change	1st Jan Change
0.197 ^EUR	-1.99%		-2.23%	-30.39%

03-26	Visiomed: share price rises on 'record' 2023 results	CF
02-13	Visiomed: 38% increase in annual sales	CF

Visiomed Group Sa Reports Earnings Results for the Full Year Ended December 31, 2020

March 30, 2021 at 09:07 pm

Visiomed Group SA announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was EUR 19 million compared to EUR 10.2 million a year ago. Operating loss was EUR 6.6 million compared to EUR 21.9 million a year ago. Net loss was EUR 5.2 million compared to EUR 24.4 million a year ago.

Latest news about Visiomed Group SA

Visiomed: share price rises on 'record' 2023 results	03-26	CF
Visiomed: 38% increase in annual sales	02-13	CF
Visiomed: new CEO appointed	01-22	CF
Visiomed: expands activities in Saudi Arabia	01-02	CF
Visiomed Group Secures Location for Plan to Build Medical Center in Saudi Arabia	01-02	MT
Visiomed Group SA's Equity Buyback announced on April 17, 2023, has expired.	18/10/23	CI
Visiomed Group SA Reports Earnings Results for the Half Year Ended June 30, 2023	09/10/23	CI
CAC40: ends the day in green despite bond tensions	21/08/23	CF
CAC40: rebound falters, rising interest rates cause concern	21/08/23	CF
CAC40: back above 7,200 despite glowing interest rates	21/08/23	CF
CAC40: starts the week in green, tops 7200 points	21/08/23	CF
Visiomed: share price rises sharply on resumption of trading	21/08/23	CF
CAC40: erases part of its losses before the close	18/08/23	CF
CAC40: decline confirmed, stagnates above 7100 pts	18/08/23	CF
CAC40: at 7100 points, the downturn deepens	18/08/23	CF
Visiomed: listing suspended	18/08/23	CF
VISIOMED : EuroLand Corporate initiates Buy coverage	08/06/23	CF
Visiomed Group SA Reports Earnings Results for the Full Year Ended December 31, 2022	26/04/23	CI
Visiomed Commences EUR44 Million Share Repurchase Program	24/04/23	MT
Visiomed: launch of share buyback program, share price surges	18/04/23	CF
Visiomed Group SA announces an Equity Buyback for 29,435,641 shares, representing 10% for €44.15 million.	16/04/23	CI
Visiomed Group SA authorizes a Buyback Plan.	16/04/23	CI
Visiomed Group: 3rd digital medical center in Dubai	09/03/23	CF
Visiomed Group to Form Healthcare JV in Saudi Arabia	17/02/23	MT
Visiomed: partnership to establish a presence in Saudi Arabia	17/02/23	CF

Chart Visiomed Group SA

Duration

Period

More charts

Company Profile

Founded in 2007, Visiomed Group SA relies on a long experience to innovative healthcare technologies and services that will shape tomorrow's health and prevention. The Group now has focused its activities on the Middle East since 2021 with the acquisition of Smart Salem, the first digital medical analysis centre accredited by the Dubai Health Authority (DHA) in the United Arab Emirates, 100% owned by Visiomed Group SA. Visiomed Group SA is also stepping up its development in the region, with the creation of Smart Health, a joint venture which will drive the deployment of the group's innovative centers in Saudi Arabia.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
VISIOMED GROUP SA	-30.39%	62.92M
ABBOTT LABORATORIES	-5.56%	181B
MEDTRONIC PLC	-0.11%	108B
BECTON, DICKINSON AND COMPANY	-6.17%	66.12B
DEXCOM, INC.	+2.64%	50.65B
CENCORA, INC.	+6.58%	43.11B
HOYA CORPORATION	+4.91%	41.3B
METTLER-TOLEDO INTERNATIONAL, INC.	+21.98%	31.6B
TERUMO CORPORATION	+14.45%	25.03B
WEST PHARMACEUTICAL SERVICES, INC.	-5.81%	24.16B

Other Medical Equipment, Supplies & Distribution